These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8761155)

  • 1. [Hyper-ferritinemia and Gaucher disease].
    Laine F; Guyader D; Turlin B; Moirand R; Deugnier Y; Brissot P
    Gastroenterol Clin Biol; 1996; 20(5):512-3. PubMed ID: 8761155
    [No Abstract]   [Full Text] [Related]  

  • 2. Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1.
    Lorenz F; Pawłowicz E; Klimkowska M; Beshara S; Bulanda Brustad A; Skotnicki AB; Wahlin A; Machaczka M
    Blood Cells Mol Dis; 2018 Feb; 68():35-42. PubMed ID: 27816428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between a serum factor and T lymphocytes in Gaucher disease.
    Bassan R; Montanelli A; Barbui T
    Am J Hematol; 1985 Apr; 18(4):381-4. PubMed ID: 3872064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ferritin concentration in Gaucher's disease.
    Morgan MA; Hoffbrand AV; Laulicht M; Luck W; Knowles S
    Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1864. PubMed ID: 6407607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Major hyperferritinemia, autoimmune thrombocytopenic purpura and lymphocytic lymphoma in Gaucher disease].
    Grosbois B; Revest M; Decaux O
    Presse Med; 2009 Dec; 38 Suppl 2():2S56-7. PubMed ID: 20304309
    [No Abstract]   [Full Text] [Related]  

  • 6. D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement.
    Shitrit D; Rudensky B; Zimran A; Elstein D
    Am J Hematol; 2003 Aug; 73(4):236-9. PubMed ID: 12879425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
    Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
    Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple myeloma in patients with Gaucher disease.
    Machaczka M; Lerner R; Klimkowska M; Hägglund H
    Am J Hematol; 2009 Oct; 84(10):694-6. PubMed ID: 19743447
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A; Marzouk I; El-Shayeb A; Wali Y
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biclonal gammapathy in type I Gaucher disease].
    Kaminsky P; Klein M; Jacob C; Deibener J; Duc M
    Presse Med; 1995 Oct; 24(30):1400. PubMed ID: 8545320
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggregation of red blood cells in patients with Gaucher disease.
    Adar T; Ben-Ami R; Elstein D; Zimran A; Berliner S; Yedgar S; Barshtein G
    Br J Haematol; 2006 Aug; 134(4):432-7. PubMed ID: 16827817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement.
    Katz K; Tamary H; Lahav J; Soudry M; Cohen IJ
    Bull Hosp Jt Dis; 1999; 58(4):188-90. PubMed ID: 10711366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinsonism among Gaucher disease carriers.
    Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
    J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease].
    Horovenko NH; Drozdova VD; Nedoboĭ AM; Ol'khovych NV; Pichkur NO; Tsyhankova MA; Radzikhovs'ka OV
    Tsitol Genet; 2006; 40(3):67-71. PubMed ID: 16933855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved high-throughput dried blood spot screening method for Gaucher disease.
    Olivova P; Cullen E; Titlow M; Kallwass H; Barranger J; Zhang K; Keutzer J
    Clin Chim Acta; 2008 Dec; 398(1-2):163-4. PubMed ID: 18812173
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease.
    Altarescu G; Zimran A; Michelakakis H; Elstein D
    Cytokine; 2005 Jul; 31(2):149-52. PubMed ID: 15919211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model.
    Rogowski O; Shapira I; Zimran A; Zeltser D; Elstein D; Attias D; Bashkin A; Berliner S
    Blood Cells Mol Dis; 2005; 34(1):26-9. PubMed ID: 15607696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention.
    Meikle PJ; Whitfield PD; Rozaklis T; Blacklock D; Duplock S; Elstein D; Zimran A; Mengel E; Cannell P; Hopwood JJ; Fuller M
    Blood Cells Mol Dis; 2008; 40(3):420-7. PubMed ID: 18054258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease: a model disorder for biomarker discovery.
    Boot RG; van Breemen MJ; Wegdam W; Sprenger RR; de Jong S; Speijer D; Hollak CE; van Dussen L; Hoefsloot HC; Smilde AK; de Koster CG; Vissers JP; Aerts JM
    Expert Rev Proteomics; 2009 Aug; 6(4):411-9. PubMed ID: 19681676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.